Pamela Esposito
2020
In 2020, Pamela Esposito earned a total compensation of $1.2M as Chief Business Officer at Replimune Group.
Compensation breakdown
| Non-Equity Incentive Plan | $102,134 |
|---|---|
| Option Awards | $762,802 |
| Salary | $362,500 |
| Total | $1,227,437 |
Esposito received $762.8K in option awards, accounting for 62% of the total pay in 2020.
Esposito also received $102.1K in non-equity incentive plan and $362.5K in salary.
Rankings
In 2020, Pamela Esposito's compensation ranked 7,737th out of 13,090 executives tracked by ExecPay. In other words, Esposito earned more than 40.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,737 out of 13,090 | 41st |
Division Manufacturing | 3,262 out of 5,621 | 42nd |
Major group Chemicals And Allied Products | 1,320 out of 2,254 | 41st |
Industry group Drugs | 1,143 out of 1,954 | 42nd |
Industry Biological Products, Except Diagnostic Substances | 271 out of 411 | 34th |
Source: SEC filing on July 29, 2020.
Esposito's colleagues
We found four more compensation records of executives who worked with Pamela Esposito at Replimune Group in 2020.